Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Segregation of QMS system requirements for different business entities

A global pharmaceutical company approached Zamann Pharma Support to provide expert guidance in segregating their Quality Management System (QMS) requirements to accommodate multiple business entities. These entities, spanning manufacturing, distribution, warehousing, and laboratory services, operated under differing regulatory and operational demands. Zamann Pharma Support proposed a tailored and systematic approach to align QMS processes with entity-specific needs while ensuring overall compliance with global and local regulatory requirements.

Challenges Faced

A detailed GAP analysis in Quality Management Systems is essential for identifying process deficiencies effectively.
  • Entity-Specific Requirements: Different business entities required QMS customization to address unique operational and compliance needs (e.g., GMP for manufacturing, GDP for distribution).
  • Complex Regulatory Landscape: The project had to comply with global standards (ISO 9001, EU GMP/GDP, ICH guidelines) while also considering regional regulatory expectations.
  • Interdependencies: Ensuring process consistency across interconnected entities without redundancy or non-compliance.
  • Time Constraints: The implementation had to be completed within a short timeframe to align with upcoming audits and regulatory inspections.

Zamann Pharma Support’s Approach

  • Project Initialization: Conducted a kick-off meeting with key stakeholders from all business entities to define goals, scope, and timelines. We performed a detailed assessment of the existing QMS framework to identify overlaps, gaps, and entity-specific requirements.
  • System Segmentation Analysis:
    1. Segregated QMS processes into core and entity-specific requirements (e.g., Change Control, CAPA, and Document Management).
    2. Identified processes that required tailoring to address specific business operations, such as warehousing vs. packaging environments.
    3. Conducted workshops with entity representatives to validate their operational requirements and regulatory responsibilities.
  • Custom QMS Design:
    1. Developed modular templates for critical QMS processes to ensure flexibility and scalability across entities.
    2. Integrated risk-based approaches to ensure alignment with EU GMP/GDP and ISO standards, prioritizing high-risk activities for stricter controls.
    3. Streamlined documentation workflows to minimize redundancy and ensure clarity across all entities.
  • Implementation Support:
    1. Delivered tailored SOPs, manuals, and training materials for each business entity.
    2. Conducted workshops to train internal teams on implementing entity-specific QMS requirements.
    3. Established a monitoring system to ensure compliance and process consistency across all entities.

Results Achieved

  • Customized Compliance: Each business entity received a tailored QMS that addressed its unique operational needs while maintaining global and local regulatory compliance.
  • Improved Efficiency: Streamlined and segmented QMS processes reduced redundancies and increased clarity, making system management more efficient.
  • Risk Mitigation: A risk-based approach ensured that high-risk areas were prioritized, reducing the likelihood of regulatory findings during audits and inspections.
  • Team Empowerment: Through workshops and hands-on training, the client’s teams gained a thorough understanding of the new QMS structure and its execution.
  • On-Time Delivery: The project was successfully completed within the defined timeline, allowing the client to prepare for upcoming inspections without delays.
Laboratory
Pharmaceutical team managing GMP Quality Management System (QMS) activities, reviewing change control records, CAPA documentation, deviation reports, and audit readiness data in a regulated manufacturing environment.
Services

Quality Management System

We work with pharmaceutical teams to design, implement, and run effective Quality Management Systems, covering change control, CAPA, deviations, and audits to support consistent GMP compliance.

Read More

Contact Us

Need help? Don't hesitate to get in touch
Zamann pharma support is committed to protecting and respecting your privacy, and we’ll use your personal information to administer your account and to provide the products and services you requested from us.

FAQ

1. How can companies effectively separate quality system requirements across multiple operational units without creating compliance gaps?

Companies should first map all existing quality processes and then segment them based on operational function such as manufacturing, distribution, and laboratory services. Additionally, they should define clear ownership for each process. This approach ensures compliance continuity, while it reduces overlap and prevents regulatory gaps during inspections.

2. What are the main regulatory challenges when implementing a segmented quality system across global operations?

Organizations often struggle with aligning different regulatory frameworks such as EU GMP, GDP, ISO standards, and ICH guidelines. Moreover, regional interpretation differences increase complexity. Therefore, companies must build a unified compliance structure with flexible, entity-specific adaptations to meet both global and local expectations effectively.

 

3. Why does a risk-based approach improve quality system segregation in complex life science organizations?

A risk-based approach helps prioritize critical processes that directly impact product quality and patient safety. As a result, organizations can allocate resources more efficiently and strengthen high-risk controls. In addition, this method reduces audit findings by ensuring consistent oversight across all interconnected business entities.